The following sections are made available to customers in order to provide in-depth information regarding stock performance and investment forecasts.
52 Week High
52 Week Low
Copyright West LLC. Minimum 15 minutes delayed.
Historic Stock Lookup
Week of June 17, 2019
Split Adjustment Factor
June 17, 2019
Year End Stock Prices
NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been
adjusted to account for any stock splits and/or dividends which may have
occurred for this security since the date shown above. The Actual Price is
not adjusted for splits or dividends. The Split Adjustment Factor is a
cumulative factor which encapsulates all splits since the date shown above.
The closing price above is not necessarily indicative of future price
Jan 02, 2014
Return calculations do not include reinvested cash dividends.
Cowen and Company
H.C. Wainwright & Co. Inc.
Ladenburg Thalmann & Co. Inc.
Roth Capital Partners, Inc.
Wedbush Securities Inc.
Stemline Therapeutics is followed by the analysts listed above. Please note
that any opinions, estimates or forecasts regarding Stemline Therapeutics's
performance made by these analysts are theirs alone and do not represent
opinions, forecasts or predictions of Stemline Therapeutics or its management.
Stemline Therapeutics does not by its reference above or distribution imply its
endorsement of or concurrence with such information, conclusions or
Director, Chief Executive Officer
Cline Darren S.
Dobmeier Eric L.
Forman Alan S.
Gionco David G.
Chief Accounting Officer
Chief Operating Officer
Zuerblis Kenneth J.
* Represents ownership of less than 1% of total shares outstanding.